Category: news 2019

Innoplexus aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt den Aktionären des Pharmakonzerns Biogen in schmerzhafter Erinnerung. Kurz vor Börsenbeginn hatte der in Cambridge, Massachusetts, aufgehende Stern am Biotech-Himmel die Investoren darüber unterrichtet, dass er eine klinische Studie mit seinem Alzheimer-Präparat „Aducanumab“ abbrechen …

Traum aller Anleger Read More »

While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific AI prediction engine, which recently caught attention by correctly predicting that Biogen’s Alzheimer’s drug aducanumab would fail with 70% to 90% certainty. Allie Nawrat finds out more. In March 2019, Biogen’s long anticipated drug for …

AI CTP engine estimated failure for Biogen’s aducanumab Read More »

While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific AI prediction engine, which recently caught attention by correctly predicting that Biogen’s Alzheimer’s drug aducanumab would fail with 70% to 90% certainty. Allie Nawrat finds out more. n March 2019, Biogen’s long anticipated drug for …

Predicting Drug Flops with AI Read More »

Gunjan Bhardwaj chose Germany as the place to launch his advanced search ­and discovery solution. His company assists the healthcare industry by organizing and analyzing vast amounts of data using ­artificial intelligence.

While the auto industry is embracing big data and its opportunities for new services and deep insights, auto companies are wary of security risks that could spark a costly backlash. Automakers can learn a lot from other industries — such as financial services, utilities and health care — that have long been traveling this road. …

Lessons Learned from Other Industries Read More »

Ob Medizin, Bankgeschäfte oder Mobilität: In Zukunft soll Künstliche Intelligenz aus dem Alltag nicht mehr wegzudenken sein. Hessische Unternehmer und Forscher wollen daran ihren Anteil haben. Uber den Titel der Studie ließe sich der eine oder andere Witz reißen: „Hessens Ambitionen für Künstliche Intelligenz“. Ambitionen, wer hätte die nicht? Doch der Inhalt ist ernst gemeint, …

Pioniere der nächsten digitalen Revolution Read More »

Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, die Profiwissen aus dem Internet und Datenbanken aufspürt und aufbereitet. Gunjan Bhardwaj (35) war auf dem besten Wege, das auskömmliche Leben eines aufstrebenden Unternehmensberaters zu führen. Arbeit und Gehalt bei Ernst & Young stimmten, das Betriebsklima war …

Google für die Gesundheitsbranche Read More »

Before Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales of about $3.7 billion by 2023. A German artificial-intelligence firm had come to a different conclusion. Innoplexus AG, a closely held company based in the outskirts of Frankfurt, uses an algorithm to analyze pharma companies’ …

An AI Firm Wants to Predicts Costly Pharma Flops Read More »

It can be hard to stay healthy in a convention center filled with thousands of people — unless, of course, you’re at the GPU Technology Conference, where healthcare players big and small are showcasing the latest innovations in AI and medicine. GTC 2019, held last week in Silicon Valley, featured more than 40 healthcare sessions, …

Finger on the Pulse: GTC Spotlights Startups Propelling AI in Healthcare Read More »